NUK - logo
E-viri
Celotno besedilo
Recenzirano
  • GTPases, genome, actin: A h...
    Magalhaes, Yuli T.; Farias, Jessica O.; Silva, Luiz E.; Forti, Fabio L.

    DNA repair, April 2021, 2021-Apr, 2021-04-00, 20210401, Letnik: 100
    Journal Article

    Display omitted •DDR and repair mechanisms have evolved to prevent harmful effects of DNA damage.•Typical Rho GTPases regulate cytoplasmic and nuclear actin dynamics.•Rho, Rac and Cdc42 are important and quasi-direct regulators of genomic stability.•DNA damage is a hallmark of cellular disorders such as cancer and premature aging.•Rho GTPases signaling are new therapeutic windows for pathophysiological disorders. The classical small Rho GTPase (Rho, Rac, and Cdc42) protein family is mainly responsible for regulating cell motility and polarity, membrane trafficking, cell cycle control, and gene transcription. Cumulative recent evidence supports important roles for these proteins in the maintenance of genomic stability. Indeed, DNA damage response (DDR) and repair mechanisms are some of the prime biological processes that underlie several disease phenotypes, including genetic disorders, cancer, senescence, and premature aging. Many reports guided by different experimental approaches and molecular hypotheses have demonstrated that, to some extent, direct modulation of Rho GTPase activity, their downstream effectors, or actin cytoskeleton regulation contribute to these cellular events. Although much attention has been paid to this family in the context of canonical actin cytoskeleton remodeling, here we provide a contextualized review of the interplay between Rho GTPase signaling pathways and the DDR and DNA repair signaling components. Interesting questions yet to be addressed relate to the spatiotemporal dynamics of this collective response and whether it correlates with different subcellular pools of Rho GTPases. We highlight the direct and indirect targets, some of which still lack experimental validation data, likely associated with Rho GTPase activation that provides compelling evidence for further investigation in DNA damage-associated events and with potential therapeutic applications in translational medicine.